This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug ACTILYSE contains one active pharmaceutical ingredient (API):
|
1
Alteplase
UNII 1RXS4UE564 - ALTEPLASE
|
|
Alteplase is a recombinant human tissue-type plasminogen activator, a glycoprotein, which activates plasminogen directly to plasmin. Once bound to fibrin, it is activated, inducing the conversion of plasminogen to plasmin leading to the dissolution of the fibrin clot. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ACTILYSE | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ACTILYSE Powder and solvent for solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B01AD02 | Alteplase | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 504500101153319, 504512030018303, 504512030018403 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29776-05-11 |
| Country: EE | Ravimiamet | Identifier(s): 1004128, 1700109, 1885383 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 59494 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 387675, 404491, 404533 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 63617876, 67177673 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 344939, 48386, 48398, 48453 |
| Country: HK | Department of Health Drug Office | Identifier(s): 30511, 37894 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7364, 7365 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1007453, 1061418, 1061419 |
| Country: MT | Medicines Authority | Identifier(s): MA211/00901, MA211/00902, MA211/00903 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13250949, 13733370 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 25747, 36870 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 13161, 4765, 4766, 4767 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100002579, 100002585, 100002622 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W00257001 |
| Country: SG | Health Sciences Authority | Identifier(s): 02340P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5253111H, 5253112H, 5253113H |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699693790026, 8699693790033, 8699693790040 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): U/31/229 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
